In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 7th, 2004 | 13 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 0.39 | 2.46 | -8.37 | 1 | 4 | 0 | 67 | 175.143 | 0 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CASP2-2-E | Caspase-2 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 1530 | 0.63 | Binding ≤ 10μM |
CASP3-1-E | Caspase-3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 149 | 0.74 | Binding ≤ 10μM |
CASP6-1-E | Caspase-6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 474 | 0.68 | Binding ≤ 10μM |
CASP7-1-E | Caspase-7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 386 | 0.69 | Binding ≤ 10μM |
CASP8-1-E | Caspase-8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1910 | 0.62 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CASP3_HUMAN | P42574 | Caspase-3, Human | 149 | 0.74 | Binding ≤ 1μM |
CASP6_HUMAN | P55212 | Caspase-6, Human | 474 | 0.68 | Binding ≤ 1μM |
CASP7_HUMAN | P55210 | Caspase-7, Human | 386 | 0.69 | Binding ≤ 1μM |
CASP2_HUMAN | P42575 | Caspase-2, Human | 1530 | 0.63 | Binding ≤ 10μM |
CASP3_HUMAN | P42574 | Caspase-3, Human | 149 | 0.74 | Binding ≤ 10μM |
CASP6_HUMAN | P55212 | Caspase-6, Human | 474 | 0.68 | Binding ≤ 10μM |
CASP7_HUMAN | P55210 | Caspase-7, Human | 386 | 0.69 | Binding ≤ 10μM |
CASP8_HUMAN | Q14790 | Caspase-8, Human | 1910 | 0.62 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of caspases through apoptosome-mediated cleavage | |
Activation of DNA fragmentation factor | |
Activation, myristolyation of BID and translocation to mitochondria | |
Apoptotic cleavage of cell adhesion proteins | |
Apoptotic cleavage of cellular proteins | |
Apoptotic execution phase | |
Breakdown of the nuclear lamina | |
Caspase-8 activation by cleavage | |
Caspase-mediated cleavage of cytoskeletal proteins | |
Degradation of the extracellular matrix | |
Dimerization of procaspase-8 | |
FasL/ CD95L signaling | |
NADE modulates death signalling | |
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | |
NOD1/2 Signaling Pathway | |
Regulation by c-FLIP | |
Role of DCC in regulating apoptosis | |
Signaling by Hippo | |
SMAC binds to IAPs | |
SMAC-mediated dissociation of IAP:caspase complexes | |
Stimulation of the cell death response by PAK-2p34 | |
TRAIL signaling | |
TRIF-mediated programmed cell death |
No pre-computed analogs available. Try a structural similarity search.